Related Experiment Video

Updated: Aug 24, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

Treatment of physiological and pathological neonatal jaundice

Stevie Boyd1

  • 1Neonatal Intensive Care Unit, Norfolk and Norwich Healthcare NHS Trust.

Nursing Times
|April 15, 2004
PubMed

Insights

Neonatal jaundice, or hyperbilirubinaemia, is common and usually harmless. However, identifying underlying pathological causes is crucial for appropriate treatment, which may include phototherapy or blood transfusions.

Area of Science:

  • Neonatology
  • Pediatrics
  • Clinical Medicine

Background:

  • Neonatal jaundice (hyperbilirubinaemia) is a frequent condition in newborns.
  • It is typically a benign, self-resolving event.
  • However, it can indicate serious underlying pathological conditions requiring medical attention.

Purpose of the Study:

  • To highlight the importance of identifying pathological causes of neonatal jaundice.
  • To outline treatment modalities for significant hyperbilirubinaemia.
  • To emphasize the role of parental involvement in managing sick infants.

Main Methods:

  • This is a review of neonatal jaundice, not a clinical study.
  • Information is synthesized from existing medical literature and clinical guidelines.
  • Focus is on clinical presentation, diagnostic considerations, and therapeutic interventions.

Main Results:

  • Most neonatal jaundice is physiological and requires no intervention.
  • A subset of infants present with pathological jaundice necessitating prompt diagnosis and treatment.
  • Effective management includes phototherapy, exchange transfusion, and addressing the root cause.

Conclusions:

  • Early identification of pathological neonatal jaundice is critical for preventing complications.
  • Treatment strategies are tailored to bilirubin levels and underlying etiologies.
  • Supportive care and parental engagement are vital components of infant management.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...